Sofrigam brings integrated cold-chain thinking to LogiPharma Montreux

Rueil Malmaison, France: – Temperature-controlled logistics specialist Sofrigam S.A. will be returning as exhibitor and sponsor to the LogiPharma 2018 show in Montreux to present its expanded range of leading-edge solutions and services that deliver an optimized pharma cool chain.

The Sofrigam stand at Booth 49 at the Montreux Exhibition Center will offer visitors opportunities to get ‘hands on’ with the company’s wide range of temperature-controlled shipping and delivery cartons, patient centric bags and pouches and data-enabled intelligent solutions.

Round the world star

Stars of the Sofrigam display will include the new Elite parcel shipper range, along with the ‘intelligent’ data-connected iBox shipper. The Sofrigam team, including Global sales manager Alain Schuerwegen and UK and Ireland project manager Peter Buchanan, will be conducting direct demonstrations of both products on the stand.

Elite is a reusable and ready to use insulated single pack out carton whose thermal efficacy and robustness was recently proved in a unique around the world test. The stand will also feature the hard case semi-active iBox that offers exceptional security for high-value consignments. Capable of functioning completely autonomously with no need of external power, the iBox can keep the products at +5°C for at least 120 hours, with integrated logger confirming temperature has been maintained.

Integrated services

“LogiPharma is a unique global end to end supply chain event and therefore the ideal platform from which to display our connected and synergistic solutions,” commented Alain Schuerwegen.

“More than ever, we have become a provider of holistic solutions that offer added value like global position tracking, accelerated package customization, cold chain auditing, , Inventory management and Track & Trace,” said Mr. Schuerwegen.

“Our advanced packaging solutions not only help secure supply chains but enhance sustainability and deliver lower total cost of ownership. We even offer a TCO calculator these days,” added Peter Buchanan.

“We can show how Sofrigam solutions like iBox embrace the concepts like Big Data, Artificial Intelligence and specific health tools that are changing the shape of pharmaceutical logistics,” said Mr. Buchanan.

About Sofrigam

With over 40 years of experience, Sofrigam provide a comprehensive portfolio of innovative packaging and related solutions that allow pharmaceutical and other clients to optimize their temperature-controlled logistic chains.

From its French roots, Sofrigam has become a global company, operating in the USA, Canada, UK and across Europe, with manufacturing centers in North America and Europe.

Sofrigam manufactures a range of standard and made-to-measure thermal packaging products, including cartons, cases, bags and pouches that cover every step in the cool chain, from manufacturer to end-user.

It also offers customized services designed to achieve secure, cost effective and ecological cold chain logistics in shipping, storage and packaging.

Sofrigam Services accompany clients through every step of the logistics chain while prioritizing safety of goods and reducing costs. Advanced software and other solutions allow clients to audit their cold chains, monitor shipments, analyze logistics lanes, manage Inventory and optimize ordering

Sofrigam can also deliver best Time to Market through thermal simulation equipment combined with its ‘cut & glue’ customization process that gives customers the ability to adapt any catalog product to its own needs with development time reduced to as little as 15 days.

About LogiPharma 2018

The LogiPharma meeting provides an annual networking and thought leadership platform for decision makers in pharma supply chain, logistics, distribution, planning, IT, quality and sourcing to meet and shape the future of their industry.

LogiPharma 2018 is a three=-day event, opening April 10 at the Montreux Music & Convention Centre, Switzerland. It will feature some 80 speakers representing supply chain players and leading pharma manufacturers.

The event is expected to attract more than 800 delegates and feature some 120 presentations and discussions. A major them for the 2018 event will be implications of the EU’s Falsified Medicines Directive and GDP guidelines.

The event is organized by WB Research with more information at: https://LogiPharmaeu.wbresearch.com.